Pfizer petitions Supreme Court over anti-kickback case, says prior opinions could 'cut off charitable or family aid'
Pfizer is taking a hotly-contested kickback case all the way to the Supreme Court, with a petition filed late last week seeking to overturn a lower court decision that barred the Big Pharma from providing financial assistance to help Medicare beneficiaries access its drug for a rare and fatal cardiac condition.
The lower courts went too far in their “sweeping interpretation” of the anti-kickback statute, Pfizer contends, noting that the view of HHS and the courts put “everyday interactions with participants in the federal health system in the statute’s crosshairs.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
